XML 36 R26.htm IDEA: XBRL DOCUMENT v3.22.2.2
Stock-Based Compensation (Tables)
3 Months Ended
Jul. 31, 2022
Share-Based Payment Arrangement [Abstract]  
Summary of Stock Option Activity
A summary of the Company’s option activity during the three months ended July 31, 2022 is as follows:
Options Outstanding
Number of
Stock Options
Outstanding
Weighted
Average
Exercise
Price
Weighted
Average
Remaining
Contractual
Life (years)
Aggregate
Intrinsic
Value
(in thousands)(in thousands)
Balance as of April 30, 202236,338 $12.44 7.34$165,436 
Options granted40 16.74 
Options exercised(287)18.88 
Options cancelled(222)13.47 
Balance as of July 31, 202235,869 $12.50 7.12$211,987 
Vested and exercisable as of July 31, 202217,698 $6.62 6.27$208,655 
Vested and expected to vest as of July 31, 2022(1)
36,169 $12.50 7.12$213,761 
(1) The number of options vested and expected to vest as of July 31, 2022 includes early exercised, unvested Class A common stock. Refer to Note 7. Stockholders’ Equity for more information.
Schedule of Valuation Assumptions The weighted average assumptions underlying the fair value estimation are provided in the following table:
As of July 31,
20222021
Valuation assumptions:
Expected dividend yield— %— %
Expected volatility45.0 %44.5 %
Expected term (years)6.56.3
Risk-free interest rate2.9 %0.8 %
Schedule of Restricted Stock Unit Activity
A summary of the Company’s RSU activity during the three months ended July 31, 2022 is as follows:
RSUs Outstanding
Number of RSUsWeighted Average
Grant Date Fair Value
Per Share
(in thousands)
Unvested Balance as of April 30, 202212,109 $36.04 
RSUs granted8,969 17.84 
RSUs vested(1,841)30.59 
RSUs forfeited(1,630)36.11 
Unvested Balance as of July 31, 202217,607 $27.29 
Summary of Effects of Stock-Based Compensation
The following table summarizes the effects of stock-based compensation on the Company’s condensed consolidated statements of operations (in thousands):
Three Months Ended July 31,
20222021
Cost of subscription$4,272 $821 
Cost of professional services1,071 602 
Sales and marketing16,779 6,135 
Research and development25,217 2,758 
General and administrative9,291 3,596 
Total stock-based compensation expense$56,630 $13,912